Communications in a medical device system with temporal optimization

• US 10,050,700 B2
• Filed: 03/02/2016
• Issued: 08/14/2018
• Est. Priority Date: 03/18/2015
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Ludwig, Jacob M., Kane, Michael J., Koop, Brendan E., Linder, William J., Maile, Keith R., Stahmann, Jeffrey E.
• Primary Examiner(s): Maung, Nay A
• Assistant Examiner(s): FLEMING-HALL, ERICA L
• Application Number:
  US15/058,412
• Publication Number:
  US 20160277097A1
• Time in Patent Office: 895 Days
• Field of Search: 455 411, 607 30- 32, 607 59- 60
• CPC Class Codes: A61B 2560/0209 adapted for power saving
• CPC Class Codes: A61B 5/0028 Body tissue as transmission medium, i.e. transmission systems where the medium is the human body
• CPC Class Codes: A61N 1/3629 in combination with non-electric therapy
• CPC Class Codes: A61N 1/37217 characterised by the communication link, e.g. acoustic or tactile
• CPC Class Codes: A61N 1/37288 Communication to several implantable medical devices within one patient
• CPC Class Codes: H04B 13/005 Transmission systems in which the medium consists of the human body
• CPC Class Codes: H04B 7/24 for communication between two or more posts wireless communication networks H04W
• CPC Class Codes: H04L 1/12 by using return channel

Abstract

Systems and methods for managing communication strategies between implanted medical devices. Methods include temporal optimization relative to one or more identified conditions in the body. A selected characteristic, such as a signal representative or linked to a biological function, is assessed to determine its likely impact on communication capabilities, and one or more communication strategies may be developed to optimize intra-body communication.

Claims

1. A first medical device comprising a communication module for communicating with a second implantable medical device and a controller operatively coupled to the communication module for at least one of receiving or transmitting messages, the controller configured to optimize communication by:

identifying a first characteristic having a possible impact on communication success;

selecting a first condition of the first characteristic on which to trigger an attempt at communication;

determining that the first condition of the first characteristic is present and attempting communication with the second implantable medical device;

assessing whether the attempted communication was successful; and

if the attempted communication was not successful, associating the first condition and first characteristic with a reduced likelihood of communication success;

wherein the first characteristic is a status of a cyclic biological phenomenon and the first condition is the occurrence of a recurring event in the cyclic biological phenomenon.

2. The first medical device of claim 1 wherein the communication module is configured for communication by conducted communication.

3. The first medical device of claim 1 wherein the first medical device is configured as an implantable medical device.

4. The first medical device of claim 1, wherein the controller is further configured to associate the first condition and first characteristic with an improved likelihood of communication success if the attempted communication was successful.

5. The first medical device of claim 1, wherein the controller is configured to further optimize communication by selecting multiple conditions of the first characteristic and repeating the determining and assessing steps for each of multiple conditions of the first characteristic to determine whether the first characteristic can be used to determine a likelihood of communication success.

6. The first medical device of claim 1, wherein the controller is configured to identify a second characteristic and test at least a first condition of the second characteristic to determine whether the second characteristic can be used to determine a likelihood of communication success.

7. The first medical device of claim 1, wherein the cyclic biological phenomenon is a cardiac cycle, and the first condition is the occurrence of one of a cardiac R-wave or a cardiac T-wave.

8. The first medical device of claim 1, wherein the cyclic biological phenomenon is a cardiac cycle, and the first condition is the occurrence of a pacing pulse.

9. The first medical device of claim 1, wherein the cyclic biological phenomenon is a respiration cycle, and the first condition is the occurrence of one of an exhale or an inhale.

10. The first medical device of claim 1, wherein the cyclic biological phenomenon is a transthoracic impedance, and the first condition is the occurrence of one of a maximum impedance or a minimum impedance.

11. An implantable medical device system comprising a first medical device as recited in claim 1 and a second implantable medical device configured for communication with the first medical device, wherein the first medical device is an intracardiac pacing device, and the second implantable medical device is a subcutaneous defibrillator.

12. An implantable medical device system comprising a first medical device as recited in claim 1, and a second implantable medical device configured for communication with the first medical device, wherein the first medical device is a subcutaneous defibrillator, and the second implantable medical device is an intracardiac pacing device.

13. A method of communication with an implantable medical device comprising:

identifying a characteristic having a possible impact on communication success;

selecting a condition of the characteristic on which to trigger an attempt at communication;

attempting communication based on the condition of the characteristic occurring;

assessing whether the communication was likely successful and;

if the communication was successful, associating the characteristic and condition with an improved likelihood of communication success;

or

if the communication was not successful, associating the characteristic and condition with a reduced likelihood of communication success; and

configuring the implantable medical device to monitor the characteristic for occurrence of the condition and avoid communication in response thereto if the characteristic and condition are associated with a reduced likelihood of communication success;

wherein the characteristic is a cyclic biological phenomenon and the condition is the occurrence of a recurring event in the cyclic biological phenomenon.

14. The method of claim 13 further comprising configuring the implantable medical device to monitor the characteristic for occurrence of the condition and communicate in response thereto if the characteristic and condition are associated with an improved likelihood of communication success.

15. The method of claim 13, wherein the cyclic biological phenomenon is one of a respiration cycle or a cardiac cycle.

16. The method of claim 13 wherein the cyclic biological phenomenon is a cardiac cycle and the first condition is the occurrence of one of a cardiac R-wave or a cardiac T-wave.

17. The method of claim 13 wherein the cyclic biological phenomenon is a cardiac cycle and the first condition is the occurrence of a pacing pulse.

18. The method of claim 13 wherein the cyclic biological phenomenon is a respiration cycle and the first condition is the occurrence of one of an exhale or an inhale.

19. The method of claim 13 wherein the cyclic biological phenomenon is a transthoracic impedance, and the first condition is the occurrence of one of a maximum impedance or a minimum impedance.